// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Clinical environmental contamination with Chlamydia trachomatis and Neisseria gonorrhoeae: is chlorine the only “solution”?

Sophie Ramsden - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An audit reviewing antibiotic prescribing for contacts of Gonorrhoea in a community clinic

Dawn Friday - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Are we achieving the standards for providing emergency contraception - findings from an integrated sexual health clinic?

Funmi Olubiyo - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Opportunistic cervical screening in post-partum women

Ciaran Gallagher - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reproductive and sexual health in a mental health setting

Alyssa Faria - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Problem bleeding in sub-dermal implant (SDI) users: an audit and management pathway

Claire Weatherburn - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Re audit comparing the use of intrauterine contraception (IUC) in an integrated sexual health service (ISHS) against the Faculty of Sexual and Reproductive Health (FSRH) guidelines

Rebecca Cannon - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Audit of the child sexual exploitation risk questionnaire (CSERQ15) in Wales

Stephanie Moore - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Preventing a COVID-19 BABY BOOM

Zainab Shather - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Uliprisnil acetate

Staff wellbeing – implementation of a contraception service for staff during Covid-19 pandemic

Mary Brown - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Coronavirus disease

N/A

Staff feedback following implementation of a telephone clinic for clinical assessment and method counselling prior to Intrauterine contraception fitting

Kimberley Forbes - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Staff views on telephone counselling prior to intrauterine contraception (IUC) fitting during COVID

Kimberley Forbes - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Assessment of contraception related telephone consultations during COVID-19 pandemic

Sandhya Garg - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Inserting Levosert devices: Has switching from the Mirena intrauterine system to the Levosert intrauterine system as the first line option for women under 45 proved cost effective in our centre?

Katie Humphries - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Levonorgestrel

The acceptability of e-prescribing services for contraceptive pills and chlamydia treatment

Tom Nadarzynski - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

STI treatment from online pharmacies - are the offers still standing?

Elizabeth Okecha - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

HIV conspiracy theories & PrEP acceptability in gay men

Daniel Jolley - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An audit of practice – “improving the assessment, coding and care of patients at risk of HIV at Homerton Sexual Health Services”

Alice Howe - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Do stigmatising misconceptions about HIV exist In 2020?

Claudia Fowler-Williams - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Human immunodeficiency virus infection

N/A

The online PrEP clinic: improving access to pre-exposure HIV prophylaxis and follow-up

Robert Brown - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved